Oak Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,315
Closed -$212K 101
2023
Q2
$212K Sell
3,315
-100
-3% -$6.71K 0.09% 98
2023
Q1
$237K Sell
3,415
-5,065
-60% -$357K 0.1% 94
2022
Q4
$610K Hold
8,480
0.27% 64
2022
Q3
$603K Buy
+8,480
New +$615K 0.29% 64
2022
Q2
Sell
-11,345
Closed -$829K 83
2022
Q1
$829K Sell
11,345
-43
-0.4% -$2.89K 0.33% 60
2021
Q4
$710K Buy
11,388
+3,750
+49% +$220K 0.27% 65
2021
Q3
$435K Sell
7,638
-85
-1% -$5.6K 0.18% 75
2021
Q2
$516K Buy
+7,723
New +$504K 0.22% 71
2021
Q1
Sell
-7,723
Closed -$479K 56
2020
Q4
$479K Hold
7,723
0.23% 72
2020
Q3
$469K Sell
7,723
-21
-0.3% -$1.26K 0.25% 71
2020
Q2
$455K Sell
7,744
-25,901
-77% -$1.55M 0.27% 66
2020
Q1
$1.88M Sell
33,645
-90
-0.3% -$5.5K 1.36% 26
2019
Q4
$2.17M Buy
33,735
+12,443
+58% +$713K 1.21% 29
2019
Q3
$1.08M Buy
21,292
+525
+3% +$24.7K 0.65% 48
2019
Q2
$888K Buy
20,767
+10,848
+109% +$505K 0.55% 51
2019
Q1
$473K Sell
9,919
-100
-1% -$4.98K 0.31% 62
2018
Q4
$521K Sell
10,019
-5,845
-37% -$314K 0.39% 56
2018
Q3
$985K Hold
15,864
0.6% 46
2018
Q2
$878K Sell
15,864
-460
-3% -$24.8K 0.6% 48
2018
Q1
$1.03M Sell
16,324
-35
-0.2% -$2.25K 0.8% 38
2017
Q4
$1M Buy
+16,359
New +$1.02M 0.76% 39

Other funds holding BMY

Oak Asset Management's BMY Position: Q3 2023 in Review

Oak Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,315 shares — an estimated $212K sold.

Oak Asset Management first reported a position in BMY in Q4 2017 and held it in 21 quarters. The position peaked at $2.17M in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Oak Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Oak Asset Management sold 3,315 Bristol-Myers Squibb shares in Q3 2023, an estimated $212K.
  • Oak Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 21 quarters.
  • Oak Asset Management's Bristol-Myers Squibb position peaked at $2.17M in Q4 2019.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Oak Asset Management's 13F filing for Q3 2023, filed 26 Oct 2023.